Macquarie Group LTD Amphastar Pharmaceuticals, Inc. Transaction History

Macquarie Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$27.56 - $37.75 $708,484 - $970,439	-25,707 Closed	0 $13,000
Q1 2022 May 16, 2022	BUY	$22.96 - $36.45 $449,074 - $712,925	19,559 Added 318.14%	25,707 $923,000
Q4 2021 Feb 11, 2022	BUY	$18.14 - $23.29 $103,289 - $132,613	5,694 Added 1254.19%	6,148 $144,000
Q1 2021 May 14, 2021	SELL	$17.21 - $20.65 $3,700 - $4,439	-215 Reduced 32.14%	454 $8,000
Q2 2020 Aug 11, 2020	BUY	$14.25 - $22.46 $9,533 - $15,025	669 New	669 $15,000

276

33.4M

56.6K

57.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.96B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.